Recurrent Non-small Cell Lung Cancer Terminated Phase 3 Trials for Erlotinib (DB00530)

Also known as: Non-Small Cell Lung Cancer Recurrent / Lung cancer non-small cell recurrent

DBCOND0028805 (Recurrent Non-small Cell Lung Cancer)Terminated3 IdentifierTitlePurposeDrugs
NCT00096265Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung CancerTreatment